33 | Monoclonal AntibodiesIBA
10/2015
-
05/2002 |
19 | Radioisotopes (Radionuclides)IBA
10/2017
-
04/2002 |
15 | AntibodiesIBA
12/2016
-
02/2004 |
15 | Trastuzumab (Herceptin)FDA Link
01/2015
-
02/2002 |
13 | Contrast MediaIBA
01/2015
-
01/2002 |
11 | Immunoconjugates (Immunoconjugate)IBA
02/2011
-
05/2002 |
11 | Chelating AgentsIBA
05/2009
-
04/2002 |
9 | AntigensIBA
05/2020
-
02/2002 |
9 | Dendrimers (Dendrons)IBA
11/2012
-
09/2003 |
8 | GadoliniumIBA
11/2012
-
01/2003 |
8 | tachpyrIBA
12/2005
-
07/2002 |
6 | Panitumumab (Vectibix)FDA Link
06/2018
-
06/2010 |
6 | Paclitaxel (Taxol)FDA LinkGeneric
06/2018
-
04/2006 |
6 | MetalsIBA
05/2014
-
07/2002 |
6 | Pharmaceutical PreparationsIBA
11/2005
-
10/2002 |
6 | IronIBA
11/2005
-
07/2002 |
5 | GemcitabineFDA Link
06/2018
-
03/2007 |
5 | LigandsIBA
07/2013
-
03/2007 |
5 | ErbB Receptors (EGF Receptor)IBA
04/2013
-
10/2005 |
5 | AvidinIBA
09/2007
-
01/2003 |
5 | IsotopesIBA
08/2007
-
08/2002 |
4 | Immunoglobulin G (IgG)IBA
06/2018
-
04/2002 |
4 | Single-Chain AntibodiesIBA
08/2008
-
02/2003 |
4 | StreptavidinIBA
01/2008
-
07/2002 |
3 | Daclizumab (Zenapax)FDA Link
05/2020
-
07/2006 |
3 | IntegrinsIBA
05/2015
-
09/2012 |
3 | Peptides (Polypeptides)IBA
09/2011
-
04/2008 |
3 | AcidsIBA
06/2010
-
07/2002 |
3 | N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
05/2009
-
09/2004 |
3 | Hu3S193 monoclonal antibodyIBA
01/2009
-
04/2006 |
3 | Therapeutic UsesIBA
02/2008
-
09/2003 |
3 | Biotin (Vitamin H)FDA Link
09/2007
-
02/2003 |
3 | PolyaminesIBA
01/2006
-
09/2004 |
3 | DOTA-biotin (90Y-DOTA-biotin)IBA
07/2005
-
07/2002 |
2 | Neoplasm Antigens (Tumor Antigens)IBA
06/2016
-
06/2004 |
2 | TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2015
-
11/2013 |
2 | tigatuzumabIBA
08/2015
-
11/2013 |
2 | Cetuximab (Erbitux)FDA Link
01/2015
-
07/2010 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2015
-
09/2012 |
2 | Biomarkers (Surrogate Marker)IBA
02/2011
-
06/2005 |
2 | Pentetic Acid (DTPA)FDA LinkGeneric
06/2010
-
08/2008 |
2 | Biological ProductsIBA
06/2010
-
06/2007 |
2 | Glycoproteins (Glycoprotein)IBA
02/2010
-
07/2005 |
2 | tumor-associated antigen 72IBA
02/2010
-
10/2005 |
2 | Lewis Y antigenIBA
11/2009
-
06/2007 |
2 | CalicheamicinsIBA
11/2009
-
04/2004 |
2 | Yttrium-90IBA
06/2009
-
09/2004 |
2 | N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
04/2008
-
07/2003 |
2 | thiol-maleimideIBA
04/2008
-
09/2007 |
2 | Astatine-211IBA
02/2008
-
08/2006 |
2 | Indium-111IBA
06/2007
-
09/2003 |
2 | Interleukin-2 Receptor alpha SubunitIBA
08/2006
-
07/2002 |
2 | Fc Receptors (Fc Receptor)IBA
07/2006
-
08/2004 |
2 | Proteins (Proteins, Gene)FDA Link
07/2005
-
02/2003 |
2 | Anti-Bacterial Agents (Antibiotics)IBA
06/2005
-
04/2004 |
2 | BismuthIBA
05/2004
-
07/2002 |
1 | Etoposide (VP 16)FDA LinkGeneric
05/2020 |
1 | Cytarabine (Cytosar-U)FDA LinkGeneric
05/2020 |
1 | Carmustine (FIVB)FDA Link
05/2020 |
1 | Melphalan (Alkeran)FDA LinkGeneric
05/2020 |
1 | RadiopharmaceuticalsIBA
01/2018 |
1 | Dihydrotachysterol (AT 10)IBA
08/2017 |
1 | Urea (Carbamide)FDA LinkGeneric
10/2016 |
1 | LuciferasesIBA
10/2016 |
1 | epacadostatIBA
06/2016 |
1 | Immunoglobulins (Immunoglobulin)IBA
08/2015 |